Victoria Cardona Selected Research

Victoria Cardona Research Topics

Disease

22	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2013
20	Hypersensitivity (Allergy) 10/2022 - 05/2008
6	Allergic Rhinitis 10/2022 - 01/2019
5	Asthma (Bronchial Asthma) 10/2021 - 01/2019
4	Food Hypersensitivity (Food Allergy) 01/2022 - 03/2006
4	Drug Hypersensitivity (Drug Allergy) 11/2021 - 01/2019
2	Infections 12/2022 - 01/2016
2	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 01/2022
2	COVID-19 02/2021 - 01/2020
2	Rhinitis 11/2019 - 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Serum Sickness 10/2019
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 10/2019
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2019
1	Cytokine Release Syndrome 10/2018
1	Bites and Stings (Sting) 01/2017
1	Latex Hypersensitivity (Latex Allergy) 01/2016
1	Hypotension (Low Blood Pressure) 04/2015
1	Vomiting 01/2014
1	Multiple Sclerosis 01/2014
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2013
1	Urticaria (Hives) 10/2013
1	Frailty 10/2011

Drug/Important Bio-Agent (IBA)

11	AllergensIBA 01/2021 - 03/2006
8	Epinephrine (Adrenaline)FDA LinkGeneric 10/2021 - 01/2014
8	Immunoglobulin E (IgE)IBA 08/2021 - 01/2014
7	Pharmaceutical PreparationsIBA 10/2022 - 01/2013
5	Tryptases (Tryptase)IBA 01/2022 - 01/2013
4	VaccinesIBA 12/2022 - 11/2012
4	Arthropod VenomsIBA 01/2022 - 01/2016
4	Biological ProductsIBA 11/2021 - 11/2012
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2013
3	COVID-19 VaccinesIBA 12/2022 - 02/2021
3	BradykininIBA 10/2018 - 04/2015
2	Proteins (Proteins, Gene)FDA Link 08/2021 - 01/2016
2	VenomsIBA 01/2021 - 02/2020
2	Heparin (Liquaemin)FDA LinkGeneric 01/2017 - 04/2015
1	azelastine (Optivar)FDA LinkGeneric 10/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	Fluticasone (Cutivate)FDA LinkGeneric 10/2022
1	TabletsIBA 03/2022
1	LatexIBA 08/2021
1	BNT162 VaccineIBA 02/2021
1	A 19IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	Nasal Decongestants (Decongestants)IBA 01/2021
1	PyrazolonesIBA 01/2021
1	AngiotensinsIBA 01/2020
1	CytokinesIBA 10/2019
1	Ertapenem (Invanz)FDA Link 07/2019
1	Meropenem (Merrem)FDA LinkGeneric 07/2019
1	carfilzomibIBA 01/2019
1	SolutionsIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Complement System Proteins (Complement)IBA 10/2018
1	LipidsIBA 01/2016
1	CarbohydratesIBA 01/2016
1	Profilins (Profilin)IBA 01/2016
1	L 644711 (B-3(+))IBA 01/2016
1	5- chloro- 3- tert- butyl- 2'- chloro- 4'- nitrosalicylanilide (S 13)IBA 01/2016
1	Seed Storage ProteinsIBA 01/2016
1	Factor XII (Hageman Factor)IBA 04/2015
1	Kininogens (Kininogen)IBA 04/2015
1	Peptide Hydrolases (Proteases)FDA Link 04/2015
1	Plasma KallikreinIBA 04/2015
1	Glatiramer Acetate (Copaxone)FDA Link 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	ThromboxanesIBA 10/2013
1	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2008

Therapy/Procedure

4	Precision Medicine 01/2022 - 10/2018
3	Self Medication 04/2019 - 01/2019
3	Immunotherapy 01/2017 - 01/2011
2	Drug Therapy (Chemotherapy) 10/2022 - 11/2019
2	Therapeutics 01/2021 - 12/2013
1	Injections 10/2021
1	Secondary Prevention 01/2020
1	Intramuscular Injections 01/2014
1	Cardiopulmonary Resuscitation (CPR) 01/2014
1	Resuscitation 01/2014
1	Polypharmacy 10/2011